Contemporary Compounding
June 15, 2018
Metronidazole 2%, Misoprostol 0.003%, Nifedipine 2%, and Phenytoin 5% Gel
Ingredients in this formula are light-sensitive, so use low light and work efficiently.May 18, 2018
Levofloxacin 50 mg/mL Oral Suspension
April 13, 2018
Nitrofurazone 0.02% Nasal Solution/Spray
February 16, 2018
Sildenafil Citrate 2.5 mg/mL Oral Liquid
January 19, 2018
Ethotoin 50 mg/mL Oral Suspension
December 15, 2017
Ranitidine Hydrochloride 25 mg/mL Syrup (Alcohol-Free)
November 17, 2017
Memantine Hydrochloride 2 mg/mL Oral Solution, Thickened
October 13, 2017
Nebivolol HCl 2.5 mg/5 mL and Valsartan 40 mg/5 mL Oral Suspension
September 15, 2017
Progesterone 50 mg/g in VersaBase Cream
June 16, 2017
Didanosine 10 mg/mL Oral Suspension
Continuing Education
$6.97 Per CE Exam or $59 for 12 Lessons
-
Dermatology • June 2020 • 2.00 Credits
Drug-Induced Severe Cutaneous Adverse Reactions: Potential Signals of Serious Risks/New Safety Information From FAERS
-
Mental Health • May 2020 • 2.00 Credits
New Therapeutic Options for the Management of ADHD
-
Infectious Disease • April 2020 • 2.00 Credits
New Vaccines and Immunization Schedule Changes
Copyright © 2000 - 2018 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.